In Vitro and In Vivo Activity of 2,4-diamino-6-[2-(3,4-dichlorophenyl)acetamido] quinazoline against Cryptococcus neoformans

dc.contributor.authorAli R. Hariri
dc.contributor.authorHoward W. Larsh
dc.date.accessioned2016-01-14T19:54:01Z
dc.date.accessioned2016-03-30T15:32:25Z
dc.date.available2016-01-14T19:54:01Z
dc.date.available2016-03-30T15:32:25Z
dc.date.issued1976-01-01
dc.description.abstractThe minimum inhibitory concentration of quinazoline derivative was determined by the tube dilution method for Cryptococcus neoformans, strain 184.en_US
dc.description.peerreviewYesen_US
dc.description.peerreviewnoteshttps://us.sagepub.com/en-us/nam/manuscript-submission-guidelinesen_US
dc.identifier.citationHariri, A. R., & Larsh, H. W. (1976). In Vitro and In Vivo Activity of 2,4-diamino-6-[2-(3,4-dichlorophenyl)acetamido] quinazoline against Cryptococcus neoformans. Experimental Biology and Medicine, 151(1), 173-176. doi: 10.3181/00379727-151-39168en_US
dc.identifier.doi10.3181/00379727-151-39168en_US
dc.identifier.urihttp://hdl.handle.net/11244/25575
dc.language.isoen_USen_US
dc.publisherExperimental Biology and Medicine
dc.rights.requestablefalseen_US
dc.titleIn Vitro and In Vivo Activity of 2,4-diamino-6-[2-(3,4-dichlorophenyl)acetamido] quinazoline against Cryptococcus neoformansen_US
dc.typeResearch Articleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
10.3181.00379727-151-39168.pdf
Size:
53.72 KB
Format:
Adobe Portable Document Format